We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IQV icon
776
IQVIA
IQV
$42.5B
$3.35M 0.01%
+12,472
New +$3.01M
2026 Q3
0 quarters
HPQ icon
777
HP
HPQ
$25.8B
$3.35M 0.01%
+106,955
New +$3.09M
2026 Q3
0 quarters
MANE icon
778
Veradermics
MANE
$5.27B
$3.34M 0.01%
+27,582
New +$3.02M
2026 Q3
0 quarters
FIX icon
779
Comfort Systems
FIX
$39.9B
$3.33M 0.01%
2,014
+1,609
+397% +$2.7M
2026 Q2
1 quarter
ROST icon
780
Ross Stores
ROST
$72.7B
$3.33M 0.01%
14,272
+10,819
+313% +$2.54M
2026 Q2
1 quarter
P icon
781
PUT
Everpure
P
$33.6B
$3.27M 0.01%
+25,000
New +$2.35M
2026 Q3
0 quarters
VKTX icon
782
CALL
Viking Therapeutics
VKTX
$3.34B
$3.26M 0.01%
+100,000
New +$3.46M
2026 Q3
0 quarters
VEEV icon
783
Veeva Systems
VEEV
$44.9B
$3.25M 0.01%
11,397
+5,677
+99% +$1.33M
2026 Q2
1 quarter
NWCL icon
784
newcleo
NWCL
$1.06B
$3.25M 0.01%
+413,987
New +$3.18M
2026 Q3
0 quarters
KRSP.U icon
785
Rice Acquisition Corp 3 Units
KRSP.U
$3.24M 0.01%
300,000
– –
2025 Q4
3 quarters
BAC icon
786
Bank of America
BAC
$337B
$3.23M 0.01%
59,334
-13,821
-19% -$842K
2026 Q1
2 quarters
ECL icon
787
Ecolab
ECL
$84.3B
$3.23M 0.01%
11,750
+8,192
+230% +$2.27M
2026 Q1
2 quarters
POLE icon
788
Andretti Acquisition Corp II
POLE
$148M
$3.22M 0.01%
300,000
-1,050,000
-78% -$11.3M
2024 Q4
7 quarters
ASML icon
789
ASML
ASML
$538B
$3.22M 0.01%
1,776
-20,009
-92% -$34.7M
2024 Q4
7 quarters
MA icon
790
Mastercard
MA
$560B
$3.21M 0.01%
5,827
-4,513
-44% -$2.54M
2026 Q1
2 quarters
SEDG icon
791
PUT
SolarEdge
SEDG
$1.3B
$3.19M 0.01%
100,000
+80,000
+400% +$3.13M
2026 Q1
2 quarters
SDHIU icon
792
Siddhi Acquisition Corp Unit
SDHIU
$220M
$3.19M 0.01%
300,000
– –
2025 Q2
5 quarters
RPM icon
793
RPM International
RPM
$13.3B
$3.18M 0.01%
+32,234
New +$3.42M
2026 Q3
0 quarters
ZYME icon
794
Zymeworks
ZYME
$1.83B
$3.18M 0.01%
120,000
+37,500
+45% +$971K
2026 Q2
1 quarter
CBZ icon
795
DELISTED
CBIZ
CBZ
$3.16M 0.01%
+57,755
New +$2.9M
2026 Q3
0 quarters
TVAIU icon
796
Thayer Ventures Acquisition Corporation II Unit
TVAIU
$3.15M 0.01%
300,000
– –
2025 Q2
5 quarters
BCSS.U icon
797
Bain Capital GSS Investment Units
BCSS.U
$3.15M 0.01%
300,000
– –
2025 Q3
4 quarters
IHS icon
798
IHS Holding
IHS
$2.86B
$3.14M 0.01%
375,766
-434,333
-54% -$3.61M
2026 Q1
2 quarters
DBCAU icon
799
D. Boral Acquisition I Corp Unit
DBCAU
$257M
$3.11M 0.01%
300,000
– –
2026 Q1
2 quarters
WPAC.U icon
800
White Pearl Acquisition Corp Units
WPAC.U
$3.11M 0.01%
300,000
– –
2026 Q1
2 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.